Literature DB >> 23188865

Devastating coagulase-negative staphylococcal septicaemia in an extremely low birth weight infant.

Sujeevan Indunil Samarasekara1, David Booth, Paul Clarke.   

Abstract

In developed countries, coagulase-negative staphylococci (CoNS) are responsible for the majority of late-onset infections in very low birth weight infants undergoing neonatal intensive care. As a common skin commensal, they are often considered as mere contaminants of peripheral blood cultures or as relatively benign bacteria clinically. We present a case of invasive CoNS septicaemia in an extremely low birth weight infant which had devastating effects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23188865      PMCID: PMC4544598          DOI: 10.1136/bcr-2012-007407

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Neonatal infections in England: the NeonIN surveillance network.

Authors:  Stefania Vergnano; Esse Menson; Nigel Kennea; Nick Embleton; Alison Bedford Russell; Timothy Watts; Michael J Robinson; Andrew Collinson; Paul T Heath
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2010-09-27       Impact factor: 5.747

Review 2.  Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system.

Authors:  Payam Rezaie; Andrew Dean
Journal:  Neuropathology       Date:  2002-09       Impact factor: 1.906

Review 3.  Coagulase-negative staphylococcal infections in the neonate and child: an update.

Authors:  Mohan P Venkatesh; Frank Placencia; Leonard E Weisman
Journal:  Semin Pediatr Infect Dis       Date:  2006-07

4.  Dynamics and clinical evolution of bacterial gut microflora in extremely premature patients.

Authors:  Aurelien Jacquot; Dorine Neveu; Fabien Aujoulat; Gregoire Mercier; Hélène Marchandin; Estelle Jumas-Bilak; Jean-Charles Picaud
Journal:  J Pediatr       Date:  2010-10-18       Impact factor: 4.406

5.  A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units.

Authors:  D Isaacs
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-03       Impact factor: 5.747

6.  Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network.

Authors:  Barbara J Stoll; Nellie Hansen; Avroy A Fanaroff; Linda L Wright; Waldemar A Carlo; Richard A Ehrenkranz; James A Lemons; Edward F Donovan; Ann R Stark; Jon E Tyson; William Oh; Charles R Bauer; Sheldon B Korones; Seetha Shankaran; Abbot R Laptook; David K Stevenson; Lu-Ann Papile; W Kenneth Poole
Journal:  Pediatrics       Date:  2002-08       Impact factor: 7.124

7.  Gut microbial colonisation in premature neonates predicts neonatal sepsis.

Authors:  Juliette C Madan; Richard Cowper Salari; Deepti Saxena; Lisa Davidson; George A O'Toole; Jason H Moore; Mitchell L Sogin; James A Foster; William H Edwards; Paul Palumbo; Patricia L Hibberd
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2012-05-06       Impact factor: 5.747

Review 8.  Antibody for the prevention of neonatal noscocomial staphylococcal infection: a review of the literature.

Authors:  L E Weisman
Journal:  Arch Pediatr       Date:  2007-09       Impact factor: 1.180

9.  Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection.

Authors:  Barbara J Stoll; Nellie I Hansen; Ira Adams-Chapman; Avroy A Fanaroff; Susan R Hintz; Betty Vohr; Rosemary D Higgins
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

10.  Postnatal infection is associated with widespread abnormalities of brain development in premature newborns.

Authors:  Vann Chau; Rollin Brant; Kenneth J Poskitt; Emily W Y Tam; Anne Synnes; Steven P Miller
Journal:  Pediatr Res       Date:  2012-01-25       Impact factor: 3.756

  10 in total
  1 in total

1.  Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol.

Authors:  Paul Clarke; Jean V Craig; John Wain; Catherine Tremlett; Louise Linsell; Ursula Bowler; Ed Juszczak; Paul T Heath
Journal:  BMJ Open       Date:  2019-02-19       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.